Why Does Clinical Trial Transparency Require Both Patient-Friendly Summaries and Strict Data Protection?
Patient-friendly summaries make trial findings understandable, while redaction and anonymisation protect participants. Sponsors need both.
Krystelis provides expert Clinical Trial Disclosure, Plain Language Services, Redaction & Anonymisation, and Policy 0070 Compliance to ensure transparency, compliance, and data protection in the life sciences industry. Learn more at Krystelis.com.